WEE1 and neoplasm: In a therapeutic setting, the quantification of Ki-67 indices revealed significant anti-proliferative effects of adavosertib, a small molecular Wee1-inhibitor, against MUC-1 but not NCI-H295R tumor spheroids (Fig. 3K, L).